Gabriela Martins Costa Gomes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gabriela Martins Costa Gomes has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Adam M. Collison
The University of Newcastle
7 shared publications - Vanessa E. Murphy
School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Breathing and Lung Health Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
7 shared publications - Joerg Mattes
Asthma & Breathing Research Program, Hunter Medical Research Institute, Newcastle, University of Newcastle, New South Wales, Australia; Paediatric Respiratory & Sleep Medicine Department, John Hunter Children's Hospital, Newcastle, New South Wales, Australia
6 shared publications - Peter Gerard Gibson
School of Medicine and Public Health The University of Newcastle New Lambton New South Wales Australia
5 shared publications - Paul D. Robinson
Children’s Health and Environment Program, Child Health Research Centre, University of Queensland, South Brisbane, Queensland, Australia
4 shared publications - Wilfried Karmaus
Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis
4 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Published by Elsevier in Environmental Research
- Vol. 306, 125251
Different effects of prenatal air pollution exposure on cord blood protein profiles and postnatal lung function in infants born to asthmatic mothers
- 13 July 2026
- Published by Elsevier in Environmental Research
- Vol. 306, 125251
Open AccessDifferent effects of prenatal air pollution exposure on cord blood protein profiles and postnatal lung function in infants born to asthmatic mothers
- Open Access
- 3 March 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (3) , 314
Early Gestational Wildfire-Related PM2.5 Exposure Is Associated with Lung Function in Offspring of Mothers with Asthma
Background: Prenatal exposure to air pollutants may increase the risk of adverse respiratory outcomes, particularly in offspring of asthmatic mothers. Evidence on wildfire-related PM2.5 exposure during pregnancy remains limited. This study investigated associations between early gestational wildfire-related PM2.5 exposure, infant lung function, and respiratory outcomes at 6 years. Methods: Gestational wildfire-related PM2.5 exposure patterns were characterised using group-based trajectory modelling and linked to infant lung function outcomes. Infant respiratory measurements were obtained at six weeks of age during behaviourally defined quiet sleep using tidal-breathing flow–volume loops (TBFVL). Airway mechanics at six years were assessed by impulse oscillometry (IOS) following international guideline standards. Trajectory modelling of PM2.5 during gestation was conducted in SAS (PROC TRAJ); all additional statistical analyses were performed in Stata IC 16.1. Results: Increased mean tidal inspiratory flow (MTIF, beta coefficient [β]: 10.51 mL/s, 95% CI: 3.66 to 17.36, p = 0.003) and peak tidal inspiratory flow (PTIF, β: 12.49 mL/s, 95% CI: 2.48 to 22.51, p = 0.014) were observed in infants born to mothers with higher wildfire-related PM2.5 exposure during early gestation (n = 420; n = 411 not exposed, n = 9 exposed). β-coefficients from infant mixed models were then used as proxy indicators and applied in linear regression models and associated with higher reactance at 5 Hz frequency (n = 73) at 6 years of age (PTIF: β: 9.88 mL/s, 95% CI: 0.10 to 19.67, p = 0.048 and MTIF: β: 13.43 mL/s, 95% CI: 1.43 to 25.44, p = 0.029). PTIF was further associated with asthma diagnoses at 6 years (aOR: 1.36, 95% CI: 1.07 to 1.73, p = 0.012; n = 259; n = 116 asthma). Conclusion: Early gestational exposure to wildfire-related PM2.5 may be linked with altered respiratory patterns in infancy and differences in airway reactance during childhood. Findings also suggest a relationship with asthma risk, although mechanisms remain uncertain.
- 3 March 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (3) , 314
Open AccessEarly Gestational Wildfire-Related PM2.5 Exposure Is Associated with Lung Function in Offspring of Mothers with Asthma
Background: Prenatal exposure to air pollutants may increase the risk of adverse respiratory outcomes, particularly in offspring of asthmatic mothers. Evidence on wildfire-related PM2.5 exposure during pregnancy remains limited. This study investigated associations between early gestational wildfire-related PM2.5 exposure, infant lung function, and respiratory outcomes at 6 years. Methods: Gestational wildfire-related PM2.5 exposure patterns were characterised using group-based trajectory modelling and linked to infant lung function outcomes. Infant respiratory measurements were obtained at six weeks of age during behaviourally defined quiet sleep using tidal-breathing flow–volume loops (TBFVL). Airway mechanics at six years were assessed by impulse oscillometry (IOS) following international guideline standards. Trajectory modelling of PM2.5 during gestation was conducted in SAS (PROC TRAJ); all additional statistical analyses were performed in Stata IC 16.1. Results: Increased mean tidal inspiratory flow (MTIF, beta coefficient [β]: 10.51 mL/s, 95% CI: 3.66 to 17.36, p = 0.003) and peak tidal inspiratory flow (PTIF, β: 12.49 mL/s, 95% CI: 2.48 to 22.51, p = 0.014) were observed in infants born to mothers with higher wildfire-related PM2.5 exposure during early gestation (n = 420; n = 411 not exposed, n = 9 exposed). β-coefficients from infant mixed models were then used as proxy indicators and applied in linear regression models and associated with higher reactance at 5 Hz frequency (n = 73) at 6 years of age (PTIF: β: 9.88 mL/s, 95% CI: 0.10 to 19.67, p = 0.048 and MTIF: β: 13.43 mL/s, 95% CI: 1.43 to 25.44, p = 0.029). PTIF was further associated with asthma diagnoses at 6 years (aOR: 1.36, 95% CI: 1.07 to 1.73, p = 0.012; n = 259; n = 116 asthma). Conclusion: Early gestational exposure to wildfire-related PM2.5 may be linked with altered respiratory patterns in infancy and differences in airway reactance during childhood. Findings also suggest a relationship with asthma risk, although mechanisms remain uncertain.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Pediatrics
- Vol. 2026 (1)
Modifiable Factors Impacting Risk of Allergic Rhinitis in Young Children: A Prospective Cohort Study
Background: This study is aimed at identifying early‐life modifiable factors associated with allergic rhinitis to assist in reducing the public health burden of allergic rhinitis on young children and their families. Methods: Children of mothers with asthma in the Breathing for Life Trial cohort were followed over 4 years. Potential risk and preventative exposures (outdoor, home environment and early life) were measured at 12 months using a validated parent‐reported questionnaire. Validated questionnaires and a skin prick test were administered to collect outcome data at 4 years—allergic rhinitis symptoms ( n = 285), hay fever ( n = 276), airborne allergen sensitisation ( n = 142) and persistent rhinitis ( n = 285). Multivariate logistic regression assessed associations, and population attributable fractions (PAFs) and prevented fractions for the population (PFPs) were calculated. Results: Parent‐reported bronchiolitis before 12 months of age was associated with allergic rhinitis symptoms (adjOR 1.95, 95% CI 1.07–3.57, PAF 17.6%). Additionally, hospitalised bronchiolitis was associated with hay fever (PAF 13.5%). Cat ownership was associated with lower odds for allergic rhinitis symptoms and persistent allergic rhinitis (PFP 17% and 24.2%, respectively), and dog ownership was associated with lower odds for hay fever (PFP 23.7%). Additionally, gas cooking was associated with reduced persistent allergic rhinitis (PFP 22.5%) and total breastfeeding for 4–6 months with reduced hay fever (PFP 14.9%). Associations with traffic frequency, second‐hand smoking, type of heating and childcare attendance were not significant. Conclusion: Early respiratory infection and cat and dog exposure were identified as potentially modifiable exposures to reduce the risk of childhood allergic rhinitis.
- 1 January 2026
- Published by Wiley in International Journal of Pediatrics
- Vol. 2026 (1)
Open AccessModifiable Factors Impacting Risk of Allergic Rhinitis in Young Children: A Prospective Cohort Study
Background: This study is aimed at identifying early‐life modifiable factors associated with allergic rhinitis to assist in reducing the public health burden of allergic rhinitis on young children and their families. Methods: Children of mothers with asthma in the Breathing for Life Trial cohort were followed over 4 years. Potential risk and preventative exposures (outdoor, home environment and early life) were measured at 12 months using a validated parent‐reported questionnaire. Validated questionnaires and a skin prick test were administered to collect outcome data at 4 years—allergic rhinitis symptoms ( n = 285), hay fever ( n = 276), airborne allergen sensitisation ( n = 142) and persistent rhinitis ( n = 285). Multivariate logistic regression assessed associations, and population attributable fractions (PAFs) and prevented fractions for the population (PFPs) were calculated. Results: Parent‐reported bronchiolitis before 12 months of age was associated with allergic rhinitis symptoms (adjOR 1.95, 95% CI 1.07–3.57, PAF 17.6%). Additionally, hospitalised bronchiolitis was associated with hay fever (PAF 13.5%). Cat ownership was associated with lower odds for allergic rhinitis symptoms and persistent allergic rhinitis (PFP 17% and 24.2%, respectively), and dog ownership was associated with lower odds for hay fever (PFP 23.7%). Additionally, gas cooking was associated with reduced persistent allergic rhinitis (PFP 22.5%) and total breastfeeding for 4–6 months with reduced hay fever (PFP 14.9%). Associations with traffic frequency, second‐hand smoking, type of heating and childcare attendance were not significant. Conclusion: Early respiratory infection and cat and dog exposure were identified as potentially modifiable exposures to reduce the risk of childhood allergic rhinitis.
Association between maternal asthma and impaired infant lung function is diminished by inhaled corticosteroid use in pregnancy
Background Infants of asthmatic mothers have reduced lung function in early life for reasons that remain to be defined. The association between inhaled corticosteroid (ICS) use during pregnancy and lung function in the offspring has not been investigated. Objectives To investigate the association between ICS use during pregnancy and infant lung function. Methods Multivariable regression analysis of infant lung function at 4–6 weeks (tidal breathing flow volume loops and functional residual capacity (FRC)) associated with use of ICS during pregnancy. Results Among infants born to asthmatic mothers, the ratio of time to peak tidal expiratory flow to expiratory time (tPTEF:tE), corrected for end-expiratory lung volume (FRC), was improved in offsprings whose mothers used ICS during pregnancy compared with those who did not (n=161 ICS use vs n=25 no ICS use; coefficient 0.06 /mL, 95% CI 0.01 to 0.11, p=0.014). Compared with a control group of infants born to non-asthmatic mothers, there was a lower tPTEF:tE to FRC ratio in infants born to asthmatic mothers without ICS use (n=46 no asthma vs n=25 asthma no ICS use; coefficient −0.08 /mL, 95% CI −0.01 to −0.02, p=0.012) but not in infants born to asthmatic mothers with ICS use (n=46 no asthma vs n=161 asthma ICS use; coefficient −0.02 /mL, 95% CI −0.06 to 0.03, p=0.453). Conclusions The association between maternal asthma and impaired infant lung function diminished in infants whose mothers used ICS during pregnancy. Trial registration Australian New Zealand Clinical Trials Registry ACTRN12613000202763.
Association between maternal asthma and impaired infant lung function is diminished by inhaled corticosteroid use in pregnancy
Background Infants of asthmatic mothers have reduced lung function in early life for reasons that remain to be defined. The association between inhaled corticosteroid (ICS) use during pregnancy and lung function in the offspring has not been investigated. Objectives To investigate the association between ICS use during pregnancy and infant lung function. Methods Multivariable regression analysis of infant lung function at 4–6 weeks (tidal breathing flow volume loops and functional residual capacity (FRC)) associated with use of ICS during pregnancy. Results Among infants born to asthmatic mothers, the ratio of time to peak tidal expiratory flow to expiratory time (tPTEF:tE), corrected for end-expiratory lung volume (FRC), was improved in offsprings whose mothers used ICS during pregnancy compared with those who did not (n=161 ICS use vs n=25 no ICS use; coefficient 0.06 /mL, 95% CI 0.01 to 0.11, p=0.014). Compared with a control group of infants born to non-asthmatic mothers, there was a lower tPTEF:tE to FRC ratio in infants born to asthmatic mothers without ICS use (n=46 no asthma vs n=25 asthma no ICS use; coefficient −0.08 /mL, 95% CI −0.01 to −0.02, p=0.012) but not in infants born to asthmatic mothers with ICS use (n=46 no asthma vs n=161 asthma ICS use; coefficient −0.02 /mL, 95% CI −0.06 to 0.03, p=0.453). Conclusions The association between maternal asthma and impaired infant lung function diminished in infants whose mothers used ICS during pregnancy. Trial registration Australian New Zealand Clinical Trials Registry ACTRN12613000202763.
- Open Access
- 27 February 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (4)
Infant respiratory outcomes following asthma management and exacerbations in pregnancy
Background: Improved maternal asthma management in pregnancy may reduce recurrent bronchiolitis and wheeze outcomes in infancy. We assessed whether infant bronchiolitis and wheeze outcomes are influenced by inflammation-guided management intervention, inhaled corticosteroid (ICS) use or exacerbations in pregnancy. Methods: A randomised controlled trial (RCT) secondary analysis and observational cohort analysis using the same study population was carried out. Pregnant women (12–23 weeks’ gestation) from six centres in Australia were recruited and randomised to inflammation-guided asthma management or usual care between 2013 and 2023. ICS use and asthma exacerbations were reported during pregnancy and postnatally. When infants were 6 (n=691) and 12 (n=606) months of age, respiratory information was collected from parents and medical records. Associations for the RCT and observational analyses were assessed with logistic regression. Results: Guided asthma management in pregnancy was not associated with bronchiolitis or wheeze-related outcomes, for example for recurrent bronchiolitis at 12 months, the intervention OR was 1.04 (95% CI 0.62–1.73). In the observational analyses, ICS use in pregnancy was not associated with respiratory outcomes; however, asthma exacerbations in pregnancy were associated with at least one bronchiolitis episode (adjusted odds ratio (adjOR) 2.20, 95% CI 1.28–3.76) or croup episode (adjOR 4.34, 95% CI 1.89–9.96) at 6 months, and wheeze (adjOR 1.80, 95% CI 1.14–2.84) and increasing wheeze episodes at 12 months (adjOR 1.81, 95% CI 1.17–2.79). Conclusion: Although there was no evidence that guided asthma management or ICS use in pregnancy reduces infant bronchiolitis or wheeze, maternal asthma exacerbations are an important risk factor for these outcomes. Further research is needed to reduce exacerbations in pregnancy.
- 27 February 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (4)
Open AccessInfant respiratory outcomes following asthma management and exacerbations in pregnancy
Background: Improved maternal asthma management in pregnancy may reduce recurrent bronchiolitis and wheeze outcomes in infancy. We assessed whether infant bronchiolitis and wheeze outcomes are influenced by inflammation-guided management intervention, inhaled corticosteroid (ICS) use or exacerbations in pregnancy. Methods: A randomised controlled trial (RCT) secondary analysis and observational cohort analysis using the same study population was carried out. Pregnant women (12–23 weeks’ gestation) from six centres in Australia were recruited and randomised to inflammation-guided asthma management or usual care between 2013 and 2023. ICS use and asthma exacerbations were reported during pregnancy and postnatally. When infants were 6 (n=691) and 12 (n=606) months of age, respiratory information was collected from parents and medical records. Associations for the RCT and observational analyses were assessed with logistic regression. Results: Guided asthma management in pregnancy was not associated with bronchiolitis or wheeze-related outcomes, for example for recurrent bronchiolitis at 12 months, the intervention OR was 1.04 (95% CI 0.62–1.73). In the observational analyses, ICS use in pregnancy was not associated with respiratory outcomes; however, asthma exacerbations in pregnancy were associated with at least one bronchiolitis episode (adjusted odds ratio (adjOR) 2.20, 95% CI 1.28–3.76) or croup episode (adjOR 4.34, 95% CI 1.89–9.96) at 6 months, and wheeze (adjOR 1.80, 95% CI 1.14–2.84) and increasing wheeze episodes at 12 months (adjOR 1.81, 95% CI 1.17–2.79). Conclusion: Although there was no evidence that guided asthma management or ICS use in pregnancy reduces infant bronchiolitis or wheeze, maternal asthma exacerbations are an important risk factor for these outcomes. Further research is needed to reduce exacerbations in pregnancy.
- Open Access
- 25 September 2024
- Published by Wiley in Clinical & Translational Immunology
- Vol. 13 (9) , e70004
Cord blood granulocyte levels are associated with severe bronchiolitis in the first year of life
Objectives: Bronchiolitis is a leading cause of infant hospitalisation in the first year of life, and it preferentially affects infants born to mothers with asthma. Here, we evaluate cord blood granulocytes in infants born to mothers with asthma participating in the Breathing for Life Trial (BLT), to investigate early life determinants of bronchiolitis hospitalisation within the first year of life.Methods: Cord blood from 89 participants was collected into EDTA tubes and processed within 6 h of birth. Cells were stained in whole cord blood for eosinophils (CD45+, CD193+, CD16−), and neutrophils (CD45+, CD193−, CD16+). Medical records were reviewed for bronchiolitis hospitalisation in the first 12 months of life. Statistical analyses were conducted using Stata IC16.1.Results: Logistic regression adjusted for caesarean section, gestational age, maternal smoking during pregnancy, foetal heart deceleration during labour, and season of birth revealed an association between cord blood eosinophil levels and bronchiolitis hospitalisation in the first 12 months of life with an Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve of 0.943 (aOR = 1.35, P = 0.011). Neutrophils were associated with the risk of bronchiolitis hospitalisation in a univariable logistic regression (OR = 0.93, P = 0.029); however, there was no statistical significance in the adjusted model.Conclusions: Higher eosinophil numbers in cord blood were associated with bronchiolitis hospitalisation in the first 12 months in a cohort of infants born to asthmatic mothers. This suggests that susceptibility to bronchiolitis in later life is influenced by the immune cell profile prior to viral infection.
- 25 September 2024
- Published by Wiley in Clinical & Translational Immunology
- Vol. 13 (9) , e70004
Open AccessCord blood granulocyte levels are associated with severe bronchiolitis in the first year of life
Objectives: Bronchiolitis is a leading cause of infant hospitalisation in the first year of life, and it preferentially affects infants born to mothers with asthma. Here, we evaluate cord blood granulocytes in infants born to mothers with asthma participating in the Breathing for Life Trial (BLT), to investigate early life determinants of bronchiolitis hospitalisation within the first year of life.Methods: Cord blood from 89 participants was collected into EDTA tubes and processed within 6 h of birth. Cells were stained in whole cord blood for eosinophils (CD45+, CD193+, CD16−), and neutrophils (CD45+, CD193−, CD16+). Medical records were reviewed for bronchiolitis hospitalisation in the first 12 months of life. Statistical analyses were conducted using Stata IC16.1.Results: Logistic regression adjusted for caesarean section, gestational age, maternal smoking during pregnancy, foetal heart deceleration during labour, and season of birth revealed an association between cord blood eosinophil levels and bronchiolitis hospitalisation in the first 12 months of life with an Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve of 0.943 (aOR = 1.35, P = 0.011). Neutrophils were associated with the risk of bronchiolitis hospitalisation in a univariable logistic regression (OR = 0.93, P = 0.029); however, there was no statistical significance in the adjusted model.Conclusions: Higher eosinophil numbers in cord blood were associated with bronchiolitis hospitalisation in the first 12 months in a cohort of infants born to asthmatic mothers. This suggests that susceptibility to bronchiolitis in later life is influenced by the immune cell profile prior to viral infection.
- Open Access
- 1 June 2023
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 7 (6) , 508-527
Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
Identifying SARS-CoV-2–specific T cell epitope–derived peptides is critical for the development of effective vaccines and measuring the duration of specific SARS-CoV-2 cellular immunity. In this regard, we previously identified T cell epitope–derived peptides within topologically and structurally essential regions of SARS-CoV-2 spike and nucleocapsid proteins by applying an immunoinformatics pipeline. In this study, we selected 30 spike- and nucleocapsid-derived peptides and assessed whether these peptides induce T cell responses and avoid major mutations found in SARS-CoV-2 variants of concern. Our peptide pool was highly specific, with only a single peptide driving cross-reactivity in people unexposed to SARS-COV-2, and immunogenic, inducing a polyfunctional response in CD4+ and CD8+ T cells from COVID-19 recovered individuals. All peptides were immunogenic and individuals recognized broad and diverse peptide repertoires. Moreover, our peptides avoided most mutations/deletions associated with all four SARS-CoV-2 variants of concern while retaining their physicochemical properties even when genetic changes are introduced. This study contributes to an evolving definition of individual CD4+ and CD8+ T cell epitopes that can be used for specific diagnostic tools for SARS-CoV-2 T cell responses and is relevant to the development of variant-resistant and durable T cell–stimulating vaccines.
- 1 June 2023
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 7 (6) , 508-527
Open AccessHighly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
Identifying SARS-CoV-2–specific T cell epitope–derived peptides is critical for the development of effective vaccines and measuring the duration of specific SARS-CoV-2 cellular immunity. In this regard, we previously identified T cell epitope–derived peptides within topologically and structurally essential regions of SARS-CoV-2 spike and nucleocapsid proteins by applying an immunoinformatics pipeline. In this study, we selected 30 spike- and nucleocapsid-derived peptides and assessed whether these peptides induce T cell responses and avoid major mutations found in SARS-CoV-2 variants of concern. Our peptide pool was highly specific, with only a single peptide driving cross-reactivity in people unexposed to SARS-COV-2, and immunogenic, inducing a polyfunctional response in CD4+ and CD8+ T cells from COVID-19 recovered individuals. All peptides were immunogenic and individuals recognized broad and diverse peptide repertoires. Moreover, our peptides avoided most mutations/deletions associated with all four SARS-CoV-2 variants of concern while retaining their physicochemical properties even when genetic changes are introduced. This study contributes to an evolving definition of individual CD4+ and CD8+ T cell epitopes that can be used for specific diagnostic tools for SARS-CoV-2 T cell responses and is relevant to the development of variant-resistant and durable T cell–stimulating vaccines.
- Open Access
- 11 October 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (25) , 2709-2721
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion
Patients with chronic lymphocytic leukemia (CLL) or monoclonal B-lymphocytosis (MBL) have impaired response to COVID-19 vaccination. A total of 258 patients (215 with CLL and 43 with MBL) had antispike antibody levels evaluable for statistical analysis. The overall seroconversion rate in patients with CLL was 94.2% (antispike antibodies ≥50 AU/mL) and 100% in patients with MBL after multiple vaccine doses. After 3 doses (post-D3) in 167 patients with CLL, 73.7% were seropositive, 17.4% had antispike antibody levels between 50 and 999 AU/mL, and 56.3% had antispike antibody levels ≥1000 AU/mL, with a median rise from 144.6 to 1800.7 AU/mL. Of patients who were seronegative post-D2, 39.7% seroconverted post-D3. For those who then remained seronegative after their previous dose, seroconversion occurred in 40.6% post-D4, 46.2% post-D5, 16.7% post-D6, and 0% after D7 or D8. After seroconversion, most had a progressive increase in antispike antibody levels. Neutralization was associated with higher antispike antibody levels, more vaccine doses, and earlier severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants; neutralizing antibody against early clade D614G was detected in 65.3%, against Delta in 52.0%, and against Omicron in 36.5%. SARS-CoV-2–specific T-cell production of interferon γ and interleukin 2 occurred in 73.9% and 60.9%, respectively, of 23 patients tested. After multiple vaccine doses, by multivariate analysis, immunoglobulin M ≥0.53 g/L, immunoglobulin subclass G3 ≥0.22 g/L and absence of current CLL therapy were independent predictors of positive serological responses. Multiple sequential COVID-19 vaccination significantly increased seroconversion and antispike antibody levels in patients with CLL or MBL.
- 11 October 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (25) , 2709-2721
Open AccessMultiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion
Patients with chronic lymphocytic leukemia (CLL) or monoclonal B-lymphocytosis (MBL) have impaired response to COVID-19 vaccination. A total of 258 patients (215 with CLL and 43 with MBL) had antispike antibody levels evaluable for statistical analysis. The overall seroconversion rate in patients with CLL was 94.2% (antispike antibodies ≥50 AU/mL) and 100% in patients with MBL after multiple vaccine doses. After 3 doses (post-D3) in 167 patients with CLL, 73.7% were seropositive, 17.4% had antispike antibody levels between 50 and 999 AU/mL, and 56.3% had antispike antibody levels ≥1000 AU/mL, with a median rise from 144.6 to 1800.7 AU/mL. Of patients who were seronegative post-D2, 39.7% seroconverted post-D3. For those who then remained seronegative after their previous dose, seroconversion occurred in 40.6% post-D4, 46.2% post-D5, 16.7% post-D6, and 0% after D7 or D8. After seroconversion, most had a progressive increase in antispike antibody levels. Neutralization was associated with higher antispike antibody levels, more vaccine doses, and earlier severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants; neutralizing antibody against early clade D614G was detected in 65.3%, against Delta in 52.0%, and against Omicron in 36.5%. SARS-CoV-2–specific T-cell production of interferon γ and interleukin 2 occurred in 73.9% and 60.9%, respectively, of 23 patients tested. After multiple vaccine doses, by multivariate analysis, immunoglobulin M ≥0.53 g/L, immunoglobulin subclass G3 ≥0.22 g/L and absence of current CLL therapy were independent predictors of positive serological responses. Multiple sequential COVID-19 vaccination significantly increased seroconversion and antispike antibody levels in patients with CLL or MBL.
- Open Access
- 12 July 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (14) , 7431
Environmental Air Pollutants Inhaled during Pregnancy Are Associated with Altered Cord Blood Immune Cell Profiles
Air pollution exposure during pregnancy may be a risk factor for altered immune maturation in the offspring. We investigated the association between ambient air pollutants during pregnancy and cell populations in cord blood from babies born to mothers with asthma enrolled in the Breathing for Life Trial. For each patient (n = 91), daily mean ambient air pollutant levels were extracted during their entire pregnancy for sulfur dioxide (SO2), nitric oxide, nitrogen dioxide, carbon monoxide, ozone, particulate matter 10) or 2.5), humidity, and temperature. Ninety-one cord blood samples were collected, stained, and assessed using fluorescence-activated cell sorting (FACS). Principal Component (PC) analyses of both air pollutants and cell types with linear regression were employed to define associations. Considering risk factors and correlations between PCs, only one PC from air pollutants and two from cell types were statistically significant. PCs from air pollutants were characterized by higher PM2.5 and lower SO2 levels. PCs from cell types were characterized by high numbers of CD8 T cells, low numbers of CD4 T cells, and by high numbers of plasmacytoid dendritic cells (pDC) and low numbers of myeloid DCs (mDCs). PM2.5 levels during pregnancy were significantly associated with high numbers of pDCs (p = 0.006), and SO2 with high numbers of CD8 T cells (p = 0.002) and low numbers of CD4 T cells (p = 0.011) and mDCs (p = 4.43 × 10−6) in cord blood. These data suggest that ambient SO2 and PM2.5 exposure are associated with shifts in cord blood cell types that are known to play significant roles in inflammatory respiratory disease in childhood.
- 12 July 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (14) , 7431
Open AccessEnvironmental Air Pollutants Inhaled during Pregnancy Are Associated with Altered Cord Blood Immune Cell Profiles
Air pollution exposure during pregnancy may be a risk factor for altered immune maturation in the offspring. We investigated the association between ambient air pollutants during pregnancy and cell populations in cord blood from babies born to mothers with asthma enrolled in the Breathing for Life Trial. For each patient (n = 91), daily mean ambient air pollutant levels were extracted during their entire pregnancy for sulfur dioxide (SO2), nitric oxide, nitrogen dioxide, carbon monoxide, ozone, particulate matter 10) or 2.5), humidity, and temperature. Ninety-one cord blood samples were collected, stained, and assessed using fluorescence-activated cell sorting (FACS). Principal Component (PC) analyses of both air pollutants and cell types with linear regression were employed to define associations. Considering risk factors and correlations between PCs, only one PC from air pollutants and two from cell types were statistically significant. PCs from air pollutants were characterized by higher PM2.5 and lower SO2 levels. PCs from cell types were characterized by high numbers of CD8 T cells, low numbers of CD4 T cells, and by high numbers of plasmacytoid dendritic cells (pDC) and low numbers of myeloid DCs (mDCs). PM2.5 levels during pregnancy were significantly associated with high numbers of pDCs (p = 0.006), and SO2 with high numbers of CD8 T cells (p = 0.002) and low numbers of CD4 T cells (p = 0.011) and mDCs (p = 4.43 × 10−6) in cord blood. These data suggest that ambient SO2 and PM2.5 exposure are associated with shifts in cord blood cell types that are known to play significant roles in inflammatory respiratory disease in childhood.
- Open Access
- 8 February 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (4) , 1597
Variation of DNA Methylation in Newborns Associated with Exhaled Carbon Monoxide during Pregnancy
Fetal exposure to tobacco smoke is an adverse risk factor for newborns. A plausible mechanism of how this exposure may negatively impact long term health is differential methylation of deoxyribonucleic acid (DNAm) and its relation to birth weight. We examined whether self-reported gestational smoking status and maternal exhaled carbon monoxide (eCO) during early pregnancy were associated with methylation of cytosine by guanines (CpG) sites that themselves predicted birth weight. We focused first on CpGs associated with maternal smoking, and secondly, among these, on CpGs related to birth weight found in another cohort. Then in 94 newborns from the Breathing for Life Trial (BLT) DNAm levels in cord blood were determined using Infinium Methylation EPIC BeadChip measuring >850K CpGs. We regressed CpGs on eCO and tested via mediation analysis whether CpGs link eCO to birth weight. Nine smoking related CpG sites were significantly associated with birth weight. Among these nine CpGs the methylation of cg02264407 on the LMO7 gene was statistically significant and linked with eCO measurements. eCO greater than six ppm showed a 2.3% decrease in infant DNAm (p = 0.035) on the LMO7 gene. A 1% decrease in methylation at this site resulted in decreased birth weight by 44.8 g (p = 0.003). None of the nine CpGs tested was associated with self-reported smoking. This is the first study to report potential mediation of DNA methylation, linking eCO measurements during early pregnancy with birth weight.
- 8 February 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (4) , 1597
Open AccessVariation of DNA Methylation in Newborns Associated with Exhaled Carbon Monoxide during Pregnancy
Fetal exposure to tobacco smoke is an adverse risk factor for newborns. A plausible mechanism of how this exposure may negatively impact long term health is differential methylation of deoxyribonucleic acid (DNAm) and its relation to birth weight. We examined whether self-reported gestational smoking status and maternal exhaled carbon monoxide (eCO) during early pregnancy were associated with methylation of cytosine by guanines (CpG) sites that themselves predicted birth weight. We focused first on CpGs associated with maternal smoking, and secondly, among these, on CpGs related to birth weight found in another cohort. Then in 94 newborns from the Breathing for Life Trial (BLT) DNAm levels in cord blood were determined using Infinium Methylation EPIC BeadChip measuring >850K CpGs. We regressed CpGs on eCO and tested via mediation analysis whether CpGs link eCO to birth weight. Nine smoking related CpG sites were significantly associated with birth weight. Among these nine CpGs the methylation of cg02264407 on the LMO7 gene was statistically significant and linked with eCO measurements. eCO greater than six ppm showed a 2.3% decrease in infant DNAm (p = 0.035) on the LMO7 gene. A 1% decrease in methylation at this site resulted in decreased birth weight by 44.8 g (p = 0.003). None of the nine CpGs tested was associated with self-reported smoking. This is the first study to report potential mediation of DNA methylation, linking eCO measurements during early pregnancy with birth weight.